The Effects Of Coenzyme Q10 Supplementation On Cardiometabolic Markers In Overweight Type 2 Diabetic Patients With Stable Myocardial Infarction: A Randomized, Double-blind, Placebo-controlled Trial
Notes for this study:
||(AU). Mean and SD. Placebo: before 13.5 ± 1.4, after 14.0 ± 2.2. Intervention: before 14.0 ± 2.4, after 14.0 ± 2.1.
|Number of Subjects
In a randomized, double-blind, placebo-controlled trial, 60 diabetic participants with coronary heart disease were allocated to 100 mg/day of coq10 or placebo for 8 weeks.
LP(a), AGEs, and thiols weren't different compared with placebo, but IL-6 saw a statistically significant decrease and so did protein carbonyls.